1019 related articles for article (PubMed ID: 10761505)
1. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
Sutter RW; Prevots DR; Cochi SL
Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
[TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
3. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
Wattigney WA; Mootrey GT; Braun MM; Chen RT
Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
[TBL] [Abstract][Full Text] [Related]
5. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
[TBL] [Abstract][Full Text] [Related]
6. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevots DR; Burr RK; Sutter RW; Murphy TV;
MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
[TBL] [Abstract][Full Text] [Related]
7. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
[TBL] [Abstract][Full Text] [Related]
8. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.
Wkly Epidemiol Rec; 2003 Jul; 78(28):241-50. PubMed ID: 15571166
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.
Miller MA; Sutter RW; Strebel PM; Hadler SC
JAMA; 1996 Sep; 276(12):967-71. PubMed ID: 8805731
[TBL] [Abstract][Full Text] [Related]
10. Paralytic poliomyelitis--United States, 1980-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
[TBL] [Abstract][Full Text] [Related]
11. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
13. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases.
Pediatrics; 1999 Jan; 103(1):171-2. PubMed ID: 9917460
[TBL] [Abstract][Full Text] [Related]
14. Poliovirus vaccine options.
Zimmerman RK; Spann SJ
Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
[TBL] [Abstract][Full Text] [Related]
15. Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics.
Pediatrics; 1999 Dec; 104(6):1404-6. PubMed ID: 10585998
[TBL] [Abstract][Full Text] [Related]
16. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(47):1017-9. PubMed ID: 9853937
[TBL] [Abstract][Full Text] [Related]
17. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
18. Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine.
Prevots DR; Strebel PM
Pediatr Ann; 1997 Jun; 26(6):378-83. PubMed ID: 9188130
[TBL] [Abstract][Full Text] [Related]
19. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
[TBL] [Abstract][Full Text] [Related]
20. Inactivated polio vaccine: time to introduce it in India's national immunization schedule.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2012 Jul; 8(7):956-8. PubMed ID: 22699444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
